<p>阿尔凯默斯（NASDAQ: ALKS）正在准备于 2026 年 2 月 25 日公布其季度财报。以下是投资者在发布前应了解的简要概述。</p>
<p>分析师预计阿尔凯默斯将报告每股收益（EPS）为 0.38 美元。</p>
<p>阿尔凯默斯的公告备受期待，投资者希望看到超出预期的消息以及对下个季度的积极指引。</p>
<p>值得新投资者注意的是，指引可能是股价波动的关键因素。</p>
<h3>之前财报的表现</h3>
<p>上个季度，该公司每股收益超出预期 0.12 美元，随后股价在第二天上涨了 1.45%。</p>
<p>以下是阿尔凯默斯过去表现及其价格变化的概览：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 预估</strong></td>
<td align="right">0.37</td>
<td align="right">0.34</td>
<td align="right">0.24</td>
<td align="right">0.76</td>
</tr>
<tr>
<td><strong>EPS 实际</strong></td>
<td align="right">0.49</td>
<td align="right">0.52</td>
<td align="right">0.13</td>
<td align="right">1.04</td>
</tr>
<tr>
<td><strong>价格变化 %</strong></td>
<td align="right">1.00</td>
<td align="right">3.00</td>
<td align="right">4.00</td>
<td align="right">7.00</td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771952541_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771952541_0.png"/></p>
<h3>阿尔凯默斯股票表现</h3>
<p>截至 2 月 23 日，阿尔凯默斯的股票交易价格为 32.19 美元。在过去 52 周内，股票下跌了 3.88%。鉴于这些回报通常是负面的，长期股东在此次财报发布前可能持悲观态度。</p>
<h3>分析师对阿尔凯默斯的看法</h3>
<p>对于投资者而言，了解市场情绪和行业预期至关重要。本分析提供了关于阿尔凯默斯的最新见解。</p>
<p>根据分析师评级，阿尔凯默斯的共识评级为，平均一年价格目标为$，存在潜在。</p>
<p>要跟踪阿尔凯默斯的所有财报发布，请访问我们网站上的财报日历。</p>
<p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>

医药突破 ETF - ALPS

纽交所高增长板生物技术指数 ETF - First Trust

医疗业 ETF - SPDR

<p>阿尔凯默斯 (NASDAQ:ALKS) 定于 2026 年 2 月 25 日公布季度财报，分析师预计每股收益 (EPS) 为 0.38 美元。该公司之前超出每股收益预期 0.12 美元，导致股价上涨 1.45%。目前，股票交易价格为 32.19 美元，过去一年下跌 3.88%，显示出长期股东的悲观情绪。分析师强调了指引在股价波动中的重要性，市场共识评级在财报发布前反映出谨慎的乐观情绪</p>

<p>Alkermes (NASDAQ: ALKS) is gearing up to announce its quarterly earnings on Wednesday, 2026-02-25. Here's a quick overview of what investors should know before the release.</p>
<div class="lb-trans"><p>阿尔凯默斯（NASDAQ: ALKS）正在准备于 2026 年 2 月 25 日公布其季度财报。以下是投资者在发布前应了解的简要概述。</p>
</div><p>Analysts are estimating that Alkermes will report an <strong>earnings per share</strong> (EPS) of $0.38.</p>
<div class="lb-trans"><p>分析师预计阿尔凯默斯将报告每股收益（EPS）为 0.38 美元。</p>
</div><p>The announcement from Alkermes is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<div class="lb-trans"><p>阿尔凯默斯的公告备受期待，投资者希望看到超出预期的消息以及对下个季度的积极指引。</p>
</div><p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<div class="lb-trans"><p>值得新投资者注意的是，指引可能是股价波动的关键因素。</p>
</div><h3>Performance in Previous Earnings</h3>
<div class="lb-trans"><h3>之前财报的表现</h3>
</div><p>Last quarter the company beat EPS by $0.12, which was followed by a 1.45% increase in the share price the next day.</p>
<div class="lb-trans"><p>上个季度，该公司每股收益超出预期 0.12 美元，随后股价在第二天上涨了 1.45%。</p>
</div><p>Here's a look at Alkermes's past performance and the resulting price change:</p>
<div class="lb-trans"><p>以下是阿尔凯默斯过去表现及其价格变化的概览：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">0.37</td>
<td align="right">0.34</td>
<td align="right">0.24</td>
<td align="right">0.76</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">0.49</td>
<td align="right">0.52</td>
<td align="right">0.13</td>
<td align="right">1.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">1.00</td>
<td align="right">3.00</td>
<td align="right">4.00</td>
<td align="right">7.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 预估</strong></td>
<td align="right">0.37</td>
<td align="right">0.34</td>
<td align="right">0.24</td>
<td align="right">0.76</td>
</tr>
<tr>
<td><strong>EPS 实际</strong></td>
<td align="right">0.49</td>
<td align="right">0.52</td>
<td align="right">0.13</td>
<td align="right">1.04</td>
</tr>
<tr>
<td><strong>价格变化 %</strong></td>
<td align="right">1.00</td>
<td align="right">3.00</td>
<td align="right">4.00</td>
<td align="right">7.00</td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771952541_0.png" alt="eps graph" original-src="https://www.benzinga.com/files/images/story/2026/1771952541_0.png"/></p>
<h3>Performance of Alkermes Shares</h3>
<div class="lb-trans"><h3>阿尔凯默斯股票表现</h3>
</div><p>Shares of Alkermes were trading at $32.19 as of February 23. Over the last 52-week period, shares are down 3.88%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.</p>
<div class="lb-trans"><p>截至 2 月 23 日，阿尔凯默斯的股票交易价格为 32.19 美元。在过去 52 周内，股票下跌了 3.88%。鉴于这些回报通常是负面的，长期股东在此次财报发布前可能持悲观态度。</p>
</div><h3>Analysts' Take on Alkermes</h3>
<div class="lb-trans"><h3>分析师对阿尔凯默斯的看法</h3>
</div><p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Alkermes.</p>
<div class="lb-trans"><p>对于投资者而言，了解市场情绪和行业预期至关重要。本分析提供了关于阿尔凯默斯的最新见解。</p>
</div><p>The consensus rating for Alkermes is , based on analyst ratings. With an average one-year price target of $, there's a potential .</p>
<div class="lb-trans"><p>根据分析师评级，阿尔凯默斯的共识评级为，平均一年价格目标为$，存在潜在。</p>
</div><p>To track all earnings releases for Alkermes visit their earnings calendar on our site.</p>
<div class="lb-trans"><p>要跟踪阿尔凯默斯的所有财报发布，请访问我们网站上的财报日历。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>
</div>

阿尔凯默斯即将发布的财报洞察